BioTuesdays

Category - Markets

ReWalk Robotics
Markets

HCW ups ReWalk Robotics to buy; PT to $9

H.C. Wainwright upgraded ReWalk Robotics (NASDAQ:RWLK) to “buy” from “neutral” and raised its price target to $9 from $4, citing several key milestones in the past few months. The stock closed at $5.21 on June 14.

June 17, 2019
Tetraphase Pharmaceuticals
Markets

HCW cuts Tetraphase Pharma PT to $1.50 from $7

H.C. Wainwright slashed its price target for Tetraphase Pharmaceuticals (NASDAQ:TTPH) to $1.50 from $7 after the company unveiled a sweeping corporate reorganization. The stock closed at 74 cents on June 12.

June 13, 2019
Markets

HCW ups Sesen Bio to buy; PT to $3

H.C. Wainwright upgraded Sesen Bio (NASDAQ:SESN) to “buy” from “neutral” and raised its price target to $3 from $1 after the company had a successful Type B pre-biologics license application (BLA) meeting with FDA for...

June 11, 2019
Intellia Therapeutics
Markets

Roth starts Intellia Therapeutics at neutral; PT $16

Roth Capital Partners launched coverage of Intellia Therapeutics (NASDAQ:NTLA) with a “neutral” rating and $16 price target, saying the stock is fully valued ahead of first-in-human studies. The stock closed at $14.36...

June 11, 2019